p-Index From 2021 - 2026
0.659
P-Index
This Author published in this journals
All Journal Atom Indonesia
Hentihu, F. K.
Unknown Affiliation

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 3 Documents
Search

Evaluation of Tumor Control Probability and Normal Tissue Complication Probability of Breast Cancer Treatment Plan in Post Mastectomy Radiation Therapy Herwiningsih, S.; Yuana, F.; Latifah, R.; Hidayat, A.; Rahmahtullah, D. P.; Alviani, I.; Hentihu, F. K.
Atom Indonesia Vol 50, No 2 (2024): AUGUST 2024
Publisher : National Research and Innovation Agency

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55981/aij.2024.1423

Abstract

Radiotherapy has been widely used to treat cancer, including breast cancer treatment, which can be given after patients undergo mastectomy procedures. This study aims to evaluate tumor control probability (TCP) and normal tissue complication probability (NTCP) of three-dimensional conformal radiation therapy (3DCRT) and intensity modulated radiation therapy (IMRT) treatment planning in post-mastectomy breast cancer radiation therapy. Twenty clinical breast cancer treatment plans delivered using 3DCRT were evaluated retrospectively. The IMRT plans were created for the same patients. The dose-volume histograms of each plan were extracted from the Treatment Planning System (TPS) computer which were then used to compute the TCP and NTCP for each plan. The TCP was calculated using the Poisson model and the NTCP was calculated using the Lyman-Kutcher-Burman (LKB) model. The NTCP was calculated for normal lung tissue, heart, esophagus, and spinal cord. The results show that the TCP of the 3DCRT and IMRT plans are not significantly different, with a value of above 99 %. The NTCP of the left lung is lower in the IMRT plans while the NTCP of the esophagus is lower in the 3DCRT plans. The NTCP for the heart, spinal cord, and right normal lung are zero in all plans.
Optimizing Quality Assurance in Breast IMRT Treatment Plans: A Comparative Study of Point Dose and 2D Dose Verification Herwiningsih, S.; Noor, J. A. E.; Widodo, C. S.; Munthe, D. Y. B.; Hentihu, F. K.
Atom Indonesia Vol 51, No 3 (2025): DECEMBER 2025
Publisher : National Research and Innovation Agency

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55981/aij.2025.1651

Abstract

Intensity-Modulated Radiation Therapy (IMRT) requires rigorous dose verification to ensure accurate radiation delivery. This study evaluates point dose verification and 2D dose verification techniques in detecting dose discrepancies due to isocenter shifts in IMRT treatment for post-mastectomy breast cancer cases. Five post-mastectomy breast IMRT plans were retrospectively analyzed, with phantom-based measurements compared against Treatment Planning System (TPS) calculations. The results indicate that point dose verification provides reliable absolute dose measurements, but lacks spatial resolution, whereas 2D verification captures dose variations more effectively. Dose discrepancies remained within acceptable limits for shifts up to ±3 mm, but shifts of ±5 mm or more resulted in clinically significant deviations. Gamma Passing Rates (GPR) decreased substantially beyond ±5 mm shifts, underscoring the importance of precise patient positioning. These findings support the integration of both verification methods to improve IMRT quality assurance, particularly in resource-limited settings. Future advancements in AI-driven dosimetry and real-time in vivo monitoring may further optimize dose verification, enhancing treatment accuracy and patient safety.
Estimating TPR₂₀,₁₀ Under Non-Reference Conditions Using a Geometric Sequence Approach Rizaldi, F. A.; Herwiningsih, S.; Widodo, C. S.; Hentihu, F. K.; Anto, A. K.
Atom Indonesia Vol 52, No 1 (2026): APRIL 2026
Publisher : National Research and Innovation Agency

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55981/aij.2026.1564

Abstract

An alternative approach to estimate the Tissue Phantom Ratio (TPR) at depths of 20 cm and 10 cm (TPR₂₀,₁₀) under non-reference conditions is required to address situations where a 10 × 10 cm² field size is not achievable on a specific Linear Accelerator (LINAC) during a beam quality test. This study aims to estimate the TPR20,10 under non-reference conditions using a geometric sequence approach, and to compare it with the TPR₂₀,₁₀ under non-reference conditions estimated using the Sauer method, the Palmas method, a linear fit approach, as well as with the TPR₂₀,₁₀ under reference conditions calculated using the TRS-398 protocol. The first step in this study was measuring the percentage depth dose (PDD), D20cm, and D10cm with field size variations from 4 × 4 cm² to 10 × 10 cm² for both 6 MV and 10 MV X-ray beams. The PDD were used to estimate the TPR₂₀,₁₀ using a geometric sequence approach, the Sauer method, the Palmans method, and a linear fit approach, and to calculate the TPR₂₀,₁₀ using the TRS-398 protocol. The D20cm and D10cm were also used to calculate the TPR₂₀,₁₀ using the TRS-398 protocol. The TPR₂₀,₁₀ for 6 MV and 10 MV X-ray beams estimated using the geometric sequence approach were 0.683 ± 0.004 and 0.742 ± 0.005, respectively. The level of precision that could be reached by the geometric sequence approach is potentially equivalent to the TRS-398 protocol, the Sauer method, the Palmans method, and the linear fit approach. The TPR₂₀,₁₀ for 6 MV and 10 MV X-ray beams estimated using the geometric sequence method did not show a significant difference compared with the TPR₂₀,₁₀ calculated using the TRS-398 protocol. However, the TPR₂₀,₁₀ for 6 MV and 10 MV X-ray beams estimated using the geometric sequence approach showed a significant difference compared with those TPR₂₀,₁₀ estimated using the Sauer method and the Palmans method.